പെഗിലേറ്റഡ് ലിപ്പോസോമൽ ഡോക്സോറൂബിസിൻ: ഹൃദയത്തിനുള്ള പാർശ്വഫലം കുറവുള്ള കാൻസറിനുള്ള മരുന്ന് Johnson Francis | August 1, 2025 | General Cardiology | No Comments Related Posts Why is not neprilysin inhibitor used alone? – Discussion No Comments | Jun 6, 2018 Which is better for heart health: Cashews or Groundnuts? No Comments | May 28, 2026 Who Needs a CT Coronary Angiogram? No Comments | Apr 18, 2024 Early Repolarization: Benign or Malignant? No Comments | Dec 17, 2025 About The Author Johnson Francis Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal